Omeros (OMER) Receivables - Net (2010 - 2026)
Omeros (OMER) reported Receivables - Net of $12.0 million for Q1 2026, up 70.04% on a YoY basis from $7.1 million in Q1 2025, and up 10.21% sequentially from $10.9 million in Q4 2025.
Omeros (OMER) Receivables - Net (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Receivables - Net data on file, last reported at $12.0 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net rose 70.04% year-over-year to $12.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (up 70.04% YoY), and the FY2025 full-year result was $10.9 million, up 41.06% from the prior year.
- Receivables - Net improved to $12.0 million in Q1 2026, from $10.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $213.2 million in Q4 2022 to a low of $6.3 million in Q2 2025.
- A 5-year average of $21.6 million and a median of $8.1 million in 2023 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net surged 458.83% in 2022 and slumped 96.2% in 2023, its largest moves.
- Tracing OMER's Receivables - Net over 5 years: stood at $213.2 million in 2022, then tumbled by 96.2% to $8.1 million in 2023, then decreased by 4.41% to $7.7 million in 2024, then soared by 41.06% to $10.9 million in 2025, then rose by 10.21% to $12.0 million in 2026.
- Business Quant data shows OMER's Receivables - Net at $12.0 million in Q1 2026, $10.9 million in Q4 2025, and $6.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.03 Mn |
| Mar 31, 2026 | 12.03 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Dec 31, 2023 | 8.10 Mn |